Results 1 to 10 of about 658,149 (311)

PB2114: TREATMENT RESULTS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA FROM HIGH-RISK GROUP

open access: yesHemaSphere, 2022
K. Filonenko   +12 more
doaj   +1 more source

Host- and Microbe-Dependent Dietary Lipid Metabolism in the Control of Allergy, Inflammation, and Immunity

open access: yesFrontiers in Nutrition, 2019
The intestine is the largest immune organ in the body, provides the first line of defense against pathogens, and prevents excessive immune reactions to harmless or beneficial non-self-materials, such as food and intestinal bacteria.
Azusa Saika   +7 more
doaj   +1 more source

Development of Nonaggregating Poly-A Tailed Immunostimulatory A/D Type CpG Oligodeoxynucleotides Applicable for Clinical Use

open access: yesJournal of Immunology Research, 2015
Immunostimulatory CpG ODNs have been developed and utilized as TLR9-dependent innate immune activators and vaccine adjuvants. Four different types of immunostimulatory CpG ODNs (A/D, B/K, C, and P type) have been reported. A/D type ODNs are characterized
Taiki Aoshi   +12 more
doaj   +1 more source

Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer

open access: yesJournal for ImmunoTherapy of Cancer, 2019
Following publication of the original article [1], the author reported an author’s family name has been misspelled. Paul Engroff should be replace Paul Engeroff.
Mona O. Mohsen   +18 more
doaj   +1 more source

Metabolism of Dietary and Microbial Vitamin B Family in the Regulation of Host Immunity

open access: yesFrontiers in Nutrition, 2019
Vitamins are micronutrients that have physiological effects on various biological responses, including host immunity. Therefore, vitamin deficiency leads to increased risk of developing infectious, allergic, and inflammatory diseases.
Ken Yoshii   +11 more
doaj   +1 more source

Vaccination with nanoparticles combined with micro-adjuvants protects against cancer

open access: yesJournal for ImmunoTherapy of Cancer, 2019
Background Induction of strong T cell responses, in particular cytotoxic T cells, is a key for the generation of efficacious therapeutic cancer vaccines which yet, remains a major challenge for the vaccine developing world. Here we demonstrate that it is
Mona O. Mohsen   +18 more
doaj   +1 more source

Adjuvant chemotherapy options for early stage non-small cell lung cancer

open access: yesFrontiers in Oncology, 2011
For many years adjuvant chemotherapy has been a standard treatment after complete resection in malignancies such as breast and colon but only recently has its use become standard in early stage non-small cell lung cancer (NSCLC).
Manali ePatel, Heather A Wakelee
doaj   +1 more source

Corrigendum: Dendritic cell proliferation by primary cilium in atopic dermatitis

open access: yesFrontiers in Molecular Biosciences, 2023
Manami Toriyama   +19 more
doaj   +1 more source

Design an Efficient Multi-Epitope Peptide Vaccine Candidate Against SARS-CoV-2: An in silico Analysis

open access: yesInfection and Drug Resistance, 2020
Zahra Yazdani,1 Alireza Rafiei,1 Mohammadreza Yazdani,2 Reza Valadan1 1Department of Immunology, Molecular and Cell Biology Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; 2Department of Chemistry, Isfahan ...
Yazdani Z   +3 more
doaj  

Home - About - Disclaimer - Privacy